The Current Ratio of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is 1.28.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-03-31 | 1.28 |
| 2023-03-31 | 1.85 |
| 2022-03-31 | 1.77 |
| 2021-03-31 | 1.75 |
| 2020-03-31 | 1.65 |
| 2019-03-31 | 1.67 |
| 2018-03-31 | 2.13 |
| 2017-03-31 | 2.54 |
| 2016-03-31 | 1.48 |
| 2015-03-31 | 1.43 |